1887

Abstract

Equine herpesvirus 1 (EHV-1) causes respiratory and neurological disease and abortion in horses. Animals with high frequencies of cytotoxic T lymphocytes (CTL) show reduced severity of respiratory disease and frequency of abortion, probably by CTL-mediated control of cell-associated viraemia. This study aimed to identify CTL epitopes restricted by selected major histocompatibility complex (MHC) class I alleles expressed in the equine leukocyte antigen (ELA) A3 haplotype. Effector CTL were induced from EHV-1-primed ponies and thoroughbreds with characterized MHC class I haplotypes and screened against P815 target cells transfected with selected EHV-1 genes and MHC class I genes. Targets that expressed EHV-1 gene 64 and the MHC B2 gene were lysed by effector CTL in a genetically restricted manner. There was no T-cell recognition of targets expressing either the MHC B2 gene and EHV-1 genes 2, 12, 14, 16, 35, 63 or 69, or the MHC C1 gene and EHV-1 genes 12, 14, 16 or 64. A vaccinia virus vector encoding gene 64 (NYVAC-64) was also investigated. Using lymphocytes from ELA-A3 horses, the recombinant NYVAC-64 virus induced effector CTL that lysed EHV-1-infected target cells; the recombinant virus also supplied a functional peptide that was expressed by target cells and recognized in an MHC-restricted fashion by CTL induced with EHV-1. This construct may therefore be used to determine the antigenicity of EHV-1 gene 64 for other MHC haplotypes. These techniques are broadly applicable to the identification of additional CTL target proteins and their presenting MHC alleles, not only for EHV-1, but for other equine viruses.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82070-0
2006-09-01
2020-10-30
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/9/2507.html?itemId=/content/journal/jgv/10.1099/vir.0.82070-0&mimeType=html&fmt=ahah

References

  1. Allen G. P. 2002; Respiratory infections by equine herpesvirus types 1 and 4. In Equine Infectious Diseases Edited by Leukeux P. Ithaca, NY: International Veterinary Information Service;
    [Google Scholar]
  2. Allen G., Yeargan M., Costa L. R., Cross R. 1995; Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1. J Virol 69:606–612
    [Google Scholar]
  3. Allen G. P., Kydd J. H., Slater J., Smith K. C. 1999; Advances in understanding of the pathogenesis, epidemiology and immunological control of equine herpesvirus abortion. In Equine Infectious Diseases vol VIII pp  129–146 Cambridge, UK: R&W Publications (Newmarket) Ltd;
    [Google Scholar]
  4. Ambagala A. P. N., Gopinath R. S., Srikumaran S. 2004; Peptide transport activity of the transporter associated with antigen processing (TAP) is inhibited by an early protein of equine herpesvirus-1. J Gen Virol 85:349–353 [CrossRef]
    [Google Scholar]
  5. Antczak D. F. 1992; The major histocompatibility complex of the horse. In Equine Infectious Diseases vol VI Cambridge, UK: R&W Publications (Newmarket) Ltd;
    [Google Scholar]
  6. Antczak D. F., Bright S. M., Remick L. H., Bauman B. E. 1982; Lymphocyte alloantigens of the horse. I. Serologic and genetic studies. Tissue Antigens 20:172–187
    [Google Scholar]
  7. Antczak D. F., Bailey E., Barger B. & 7 other authors 1986; Joint report of the Third International Workshop on Lymphocyte Alloantigens of the Horse, Kennett Square, Pennsylvania, 25–27 April 1984. Anim Genet 17:363–373
    [Google Scholar]
  8. Bailey E., Marti E., Fraxer D. G., Antczak D. F., Lazary S. 2000; Immunogenetics of the horse. In The Genetics of the Horse pp  123–155 Edited by Bowling A. T., Ruvinsky A. Wallingford, UK: CABI Publishing;
    [Google Scholar]
  9. Bodo G., Marti E., Gaillard C., Weiss M., Bruckner L., Gerber H., Lazary S. 1994; Association of the immune response with the major histocompatibility complex in the horse. In Equine Infectious Diseases vol VII pp  143–151 Edited by Nakajima H., Plowright W. Newmarket, UK: R&W Publications (Newmarket) Ltd;
    [Google Scholar]
  10. Charan S., Palmer K., Chester P., Mire-Sluis A. R., Meager A., Edington N. 1997; Transforming growth factor-beta induced by live or ultraviolet-inactivated equid herpes virus type-1 mediates immunosuppression in the horse. Immunology 90:586–591 [CrossRef]
    [Google Scholar]
  11. Chung C., Leib S. R., Fraser D. G., Ellis S. A., McGuire T. C. 2003; Novel classical MHC class I alleles identified in horses by sequencing clones of reverse transcription-PCR products. Eur J Immunogenet 30:387–396 [CrossRef]
    [Google Scholar]
  12. Edington N., Welch H. M., Griffiths L. 1994; The prevalence of latent equid herpesviruses in the tissues of 40 abattoir horses. Equine Vet J 26:140–142 [CrossRef]
    [Google Scholar]
  13. Ellis S. A., Martin A. J., Holmes E. C., Morrison W. I. 1995; At least four MHC class I genes are transcribed in the horse: phylogenetic analysis suggests an unusual evolutionary history for the MHC in this species. Eur J Immunogenet 22:249–260 [CrossRef]
    [Google Scholar]
  14. Grundy F. J., Baumann R. P., O'Callaghan D. J. 1989; DNA sequence and comparative analyses of the equine herpesvirus type 1 immediate early gene. Virology 172:223–236 [CrossRef]
    [Google Scholar]
  15. Gustafson A. L., Tallmadge R. L., Ramlachan N., Miller D., Bird H., Antczak D. F., Raudsepp T., Chowdhary B. P., Skow L. C. 2003; An ordered BAC contig map of the equine major histocompatibility complex. Cytogenet Genome Res 102:189–195 [CrossRef]
    [Google Scholar]
  16. Hannant D., Jessett D., O'Neill T., Dolby C. A., Cook R. F., Mumford J. A. 1993; Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus to the homologous strain. Res Vet Sci 54:299–305 [CrossRef]
    [Google Scholar]
  17. Hannant D., O'Neill T., Ostlund E. N., Kydd J. H., Hopkin P. J., Mumford J. A. 1999; Equid herpesvirus-induced immunosuppression is associated with lymphoid cells and not soluble circulating factors. Viral Immunol 12:313–321 [CrossRef]
    [Google Scholar]
  18. Heldens J. G. M., Hannant D., Cullinane A. A., Prendergast M. J., Mumford J. A., Nelly M., Kydd J. H., Weststrate M. W., van den Hoven R. 2001; Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares. Vaccine 19:4307–4317 [CrossRef]
    [Google Scholar]
  19. Huemer H. P., Nowotny N., Crabb B. S., Meyer H., Hubert P. H. 1995; gp13(EHV-gC): a complement receptor induced by equine herpesviruses. Virus Res 37:113–126 [CrossRef]
    [Google Scholar]
  20. Klenerman P., Cerundolo V., Dunbar P. R. 2002; Tracking T cells with tetramers: new tales from new tools. Nat Rev Immunol 2:263–272 [CrossRef]
    [Google Scholar]
  21. Kydd J. H., Wattrang E., Hannant D. 2003; Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares. Vet Immunol Immunopathol 96:207–217 [CrossRef]
    [Google Scholar]
  22. Mealey R. H., Sharif A., Ellis S. A., Littke M. H., Leib S. R., McGuire T. C. 2005; Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes. Virology 339:110–126 [CrossRef]
    [Google Scholar]
  23. Minke J. M., Audonnet J. C., Fischer L. 2004; Equine viral vaccines: the past, present and future. Vet Res 35:425–443 [CrossRef]
    [Google Scholar]
  24. Mumford J. A. 1994; Abortigenic and neurological disease caused by experimental infection with equid herpesvirus-1. In Equine Infectious Diseases vol. VII pp  261–276 Edited by Nakajima H., Plowright W. Cambridge, UK: R&W Publications (Newmarket) Ltd;
    [Google Scholar]
  25. O'Neill T., Kydd J. H., Allen G. P., Wattrang E., Mumford J. A., Hannant D. 1999; Determination of equid herpesvirus 1-specific, CD8+, cytotoxic T lymphocyte precursor frequencies in ponies. Vet Immunol Immunopathol 70:43–54 [CrossRef]
    [Google Scholar]
  26. Paillot R., Daly J. M., Juillard V., Minke J. M., Hannant D., Kydd J. H. 2005; Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1. Vaccine 23:4541–4551 [CrossRef]
    [Google Scholar]
  27. Paillot R., Ellis S. A., Daly J. M., Audonnet J. C., Minke J. M., Davis-Poynter N., Hannant D., Kydd J. H. 2006; Characterisation of CTL and IFN γ synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection. Vaccine 24:1490–1500 [CrossRef]
    [Google Scholar]
  28. Patel J. R., Heldens J. 2005; Equine herpesviruses 1 (EHV-1) and 4 (EHV-4) – epidemiology, disease and immunoprophylaxis: a brief review. Vet J 170:14–23 [CrossRef]
    [Google Scholar]
  29. Piccini A., Perkus M. E., Paoletti E. 1987; Vaccinia virus as an expression vector. Methods Enzymol 153:545–563
    [Google Scholar]
  30. Rappocciolo G., Birch J., Ellis S. A. 2003; Down-regulation of MHC class I expression by equine herpesvirus-1. J Gen Virol 84:293–300 [CrossRef]
    [Google Scholar]
  31. Sinclair R., Cook R. F., Mumford J. A. 1989; The characterization of neutralizing and non-neutralizing monoclonal antibodies against equid herpesvirus type 1. J Gen Virol 70:455–459 [CrossRef]
    [Google Scholar]
  32. Slater J. D., Borchers K., Thackray A. M., Field H. J. 1994; The trigeminal ganglion is a location for equine herpesvirus 1 latency and reactivation in the horse. J Gen Virol 75:2007–2016 [CrossRef]
    [Google Scholar]
  33. Soboll G., Whalley J. M., Koen M. T., Allen G. P., Fraser D. G., Macklin M. D., Swain W. F., Lunn D. P. 2003; Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytes. J Gen Virol 84:2625–2634 [CrossRef]
    [Google Scholar]
  34. Tallmadge R. L., Lear T., Antczak D. F. 2005; Genomic characterization of MHC class I genes of the horse. Immunogenetics 57:763–774 [CrossRef]
    [Google Scholar]
  35. Tartaglia J., Perkus M. E., Taylor J. & 9 other authors 1992; NYVAC: a highly attenuated strain of vaccinia virus. Virology 188:217–232 [CrossRef]
    [Google Scholar]
  36. Telford E. A., Watson M. S., McBride K., Davison A. J. 1992; The DNA sequence of equine herpesvirus-1. Virology 189:304–316 [CrossRef]
    [Google Scholar]
  37. Thomson G. R., Mumford J. A., Campbell J., Griffiths L., Clapham P. 1976; Serological detection of equid herpesvirus 1 infections of the respiratory tract. Equine Vet J 8:58–65 [CrossRef]
    [Google Scholar]
  38. Welch H. M., Bridges C. G., Lyon A. M., Griffiths L., Edington N. 1992; Latent equid herpesviruses 1 and 4: detection and distinction using the polymerase chain reaction and co-cultivation from lymphoid tissues. J Gen Virol 73:261–268 [CrossRef]
    [Google Scholar]
  39. Zhang Y., Smith P. M., Tarbet E. B., Osterrieder N., Jennings S. R., O'Callaghan D. J. 1998; Protective immunity against equine herpesvirus type-1 (EHV-1) infection in mice induced by recombinant EHV-1 gD. Virus Res 56:11–24 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82070-0
Loading
/content/journal/jgv/10.1099/vir.0.82070-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error